Forward P/S Multiple: Autonomix Medical Inc. (AMIX)

The absence of direct competitors in the neuromodulation niche provides Autonomix Medical, Inc. (AMIX) with high margins, as confirmed by the forward P/S indicator trajectory on the GURU.Markets chart, where the value shows the latest reading. Growth is driven by developments in cancer pain management and clinic interest in non-opioid methods. Production relies on a fabless model with final assembly at certified US facilities.

Forward P/S determines the market value of an asset relative to expected sales volume, allowing an investor to assess the extent of overpayment for future revenue growth. By analyzing the forward P/S multiple, one can compare the current capitalization of Autonomix Medical (AMIX) with the sales potential of neuroablative catheters, where the resilience of electronics supply chains converts directly into the stability of future cash flows and operational efficiency.